Donoghue Forlines LLC’s Bristol-Myers Squibb Co Position
Does Donoghue Forlines LLC own Bristol-Myers Squibb Co (BMY)? Yes — 83.4K shares worth $5M (+1.40% of its 13F portfolio) as of Q1 2026, up from 29.0K shares the prior filed quarter.
Position Value
$5M
Q1 2026
Shares
83.4K
% of Portfolio
+1.40%
Quarters Held
27
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 83.4K | $5M | +1.40% |
| Q4 2025 | 29.0K | $2M | +0.48% |
| Q3 2025 | 31.5K | $1M | +0.44% |
| Q2 2025 | 29.4K | $1M | +0.39% |
| Q1 2025 | 24.3K | $1M | +0.47% |
| Q4 2024 | 27.8K | $2M | +0.53% |
| Q3 2024 | 17.7K | $915,539 | +0.26% |
| Q2 2024 | 16.7K | $695,461 | +0.20% |
| Q1 2024 | 14.5K | $785,467 | +0.22% |
| Q4 2023 | 10.6K | $543,476 | +0.17% |
| Q3 2023 | 22.1K | $1M | +0.46% |
| Q2 2023 | 16.0K | $1M | +0.32% |
| Q1 2023 | 12.7K | $882,940 | +0.32% |
| Q4 2022 | 35.2K | $3M | +0.89% |
| Q3 2022 | 15.0K | $1M | +0.39% |
| Q2 2022 | 37.7K | $3M | +0.76% |
| Q1 2022 | 45.2K | $3M | +0.72% |
| Q4 2021 | 23.6K | $1M | +0.25% |
| Q3 2021 | 40.7K | $2M | +0.47% |
| Q2 2021 | 41.4K | $3M | +0.52% |
| Q1 2021 | 41.8K | $3M | +0.51% |
| Q4 2020 | 23.6K | $1M | +0.28% |
| Q3 2020 | 20.1K | $1M | +0.33% |
| Q1 2020 | 13.4K | $748,000 | +0.17% |
| Q4 2019 | 51.4K | $3M | +0.51% |
| Q3 2019 | 88.7K | $4M | +0.64% |
| Q2 2019 | 143.6K | $7M | +0.76% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Donoghue Forlines LLC’s full portfolio or all institutional holders of BMY.